-The Times of India MUMBAI: It's widely known that a month's dose of cancer drugs can cost lakhs, but what isn't common knowledge is that Tata Memorial Hospital's doctors are working on alternatives that could cost less than Rs 1,000 a month. Dubbed the metronomic treatment protocol, it comprises daily consumption of a combination of low-dose medicines that are cheap because they have been around for decades. "There is no need to...
More »SEARCH RESULT
Total Matching Records found : 843
Ranbaxy case may take a toll on other Indian drug makers
-The Business Standard The tussle between the US Food and Drug Administration (US FDA) and Ranbaxy is likely to hit the plans of Indian pharmaceutical companies of making it big in the US generic drugs market. Apart from the fact that their image may take a beating, the additional scrutiny on abbreviated new drug applications (ANDAs) from India would lead to more delays in drug approvals. Last week, Ranbaxy had agreed to...
More »Inequality re-emerges as a core concern, needs a new definition-Ali Mehdi
-The Economic Times What is... Inequality has re-emerged as a core concern in developing and developed countries alike, thanks to the growing gap and frustration of a section of the middle class and the rich vis-a-vis the super rich. A World Bank Policy Research Working Paper (No. 6259) by Branko Milanovic shows that the incomes of the global top 1 per cent and the emerging middle classes in developing countries rose dramatically between...
More »Frontiers without doctors-D Thamma Rao
-The Hindu The south leads in the number of medical and nursing seats, with for-profit private colleges dominating the scene. It will take major capacity expansion in the government sector to meet WHO norms on access to health professionals. India has achieved major organisational and technological successes but the health system's performance is abysmal. This cannot be attributed to poverty. It is poor health that places India 134th in the Human Development...
More »Time to let the caged bird sing-Raju Ramachandran
-The Hindu In making a case for the investigative agency's autonomy, the Supreme Court is only stepping in where the executive has failed The proceedings in the Coalgate case earlier this week saw the Supreme Court asking the Central Bureau of Investigation (CBI) many uncomfortable questions. The Court also asked the government to tell it what steps it was going to take to enact a law to ensure the CBI's autonomy. The...
More »
